Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akiyo Yoshida

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
International Journal of Hematology|June 5, 2025
Transient lupus anticoagulant induced by adenovirus cystitis in a bone marrow transplant recipientTatsuya Imi, Hidesaku Asakura, Keijiro Sato, et al.
International Journal of Hematology|October 27, 2025
Epcoritamab as bridging therapy to successful second allogeneic HSCT in relapsed DLBCL after UCBT and CAR T cell therapyYui Chikagawa, Daiki Higashi, Satoomi Sakai, et al.
Cancer Research|June 14, 2019
Retinoblastoma Inactivation Induces a Protumoral Microenvironment via Enhanced CCL2 SecretionFengkai Li, Shunsuke Kitajima, Susumu Kohno, et al.
Journal of Medical Systems|March 8, 2024
3D CNN-based Deep Learning Model-based Explanatory Prognostication in Patients  with Multiple Myeloma using Whole-body MRIKento Morita, Shigehiro Karashima, Toshiki Terao, et al.
Oncotarget|January 19, 2017
MicroRNA-140 mediates RB tumor suppressor function to control stem cell-like activity through interleukin-6Akiyo Yoshida, Shunsuke Kitajima, Fengkai Li, et al.
Hematological Oncology|September 26, 2020
Consolidation with <sup>90</sup> Yttrium-ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphomaKatsuhiro Miura, Hideki Tsujimura, Yasufumi Masaki, et al.
British Journal of Haematology|April 15, 2026
Decreased renal function predicts severe cytokine release syndrome after CAR-T-cell therapy for large B-cell lymphomaYasuyuki Arai, Tomoyasu Jo, Takayuki Sato, et al.
Bone Marrow Transplantation|February 14, 2026
Disease status at CAR T-cell infusion in relapsed or refractory large B-cell lymphoma: prognostic significance for real-world outcomes, irrespective of bridging therapyYu Yagi, Yusuke Kanemasa, Hideki Goto, et al.
Blood Neoplasia|June 23, 2025
Low platelet counts and low CD4/CD8 ratios at apheresis increase the risk of CAR T-cell manufacturing failure in myelomaTomoyasu Jo, Kyoko Yoshihara, Masaki Ri, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
International Journal of Hematology|June 5, 2025
Transient lupus anticoagulant induced by adenovirus cystitis in a bone marrow transplant recipientTatsuya Imi, Hidesaku Asakura, Keijiro Sato, et al.
International Journal of Hematology|October 27, 2025
Epcoritamab as bridging therapy to successful second allogeneic HSCT in relapsed DLBCL after UCBT and CAR T cell therapyYui Chikagawa, Daiki Higashi, Satoomi Sakai, et al.
Cancer Research|June 14, 2019
Retinoblastoma Inactivation Induces a Protumoral Microenvironment via Enhanced CCL2 SecretionFengkai Li, Shunsuke Kitajima, Susumu Kohno, et al.
Journal of Medical Systems|March 8, 2024
3D CNN-based Deep Learning Model-based Explanatory Prognostication in Patients  with Multiple Myeloma using Whole-body MRIKento Morita, Shigehiro Karashima, Toshiki Terao, et al.
Oncotarget|January 19, 2017
MicroRNA-140 mediates RB tumor suppressor function to control stem cell-like activity through interleukin-6Akiyo Yoshida, Shunsuke Kitajima, Fengkai Li, et al.
Hematological Oncology|September 26, 2020
Consolidation with <sup>90</sup> Yttrium-ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphomaKatsuhiro Miura, Hideki Tsujimura, Yasufumi Masaki, et al.
British Journal of Haematology|April 15, 2026
Decreased renal function predicts severe cytokine release syndrome after CAR-T-cell therapy for large B-cell lymphomaYasuyuki Arai, Tomoyasu Jo, Takayuki Sato, et al.
Bone Marrow Transplantation|February 14, 2026
Disease status at CAR T-cell infusion in relapsed or refractory large B-cell lymphoma: prognostic significance for real-world outcomes, irrespective of bridging therapyYu Yagi, Yusuke Kanemasa, Hideki Goto, et al.
Blood Neoplasia|June 23, 2025
Low platelet counts and low CD4/CD8 ratios at apheresis increase the risk of CAR T-cell manufacturing failure in myelomaTomoyasu Jo, Kyoko Yoshihara, Masaki Ri, et al.
Pageof 2